다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

ARGX

argenx (ARGX)

argenx SE

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ARGX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/03/07	20:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ARGX	argenx SE
2025/03/07	15:00	GlobeNewswire Inc.	argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting	NASDAQ:ARGX	argenx SE
2025/02/27	20:34	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ARGX	argenx SE
2025/02/27	15:00	GlobeNewswire Inc.	argenx Reports Full Year 2024 Financial Results and Provides Fourth Quarter Business Update	NASDAQ:ARGX	argenx SE
2025/02/25	15:00	GlobeNewswire Inc.	argenx to Present at TD Cowen 45th Annual Healthcare Conference	NASDAQ:ARGX	argenx SE
2025/02/20	15:00	GlobeNewswire Inc.	argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025	NASDAQ:ARGX	argenx SE
2025/02/12	23:16	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:ARGX	argenx SE
2025/01/13	15:00	GlobeNewswire Inc.	argenx Highlights 2025 Strategic Priorities	NASDAQ:ARGX	argenx SE
2025/01/06	15:00	GlobeNewswire Inc.	argenx to Present at 43rd Annual J.P. Morgan Healthcare Conference	NASDAQ:ARGX	argenx SE
2024/12/27	20:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ARGX	argenx SE
2024/12/27	15:00	GlobeNewswire Inc.	argenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating Polyneuropathy	NASDAQ:ARGX	argenx SE
2024/11/26	15:00	GlobeNewswire Inc.	argenx to Present at Upcoming Investor Conferences	NASDAQ:ARGX	argenx SE
2024/11/20	20:35	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ARGX	argenx SE
2024/11/20	15:00	GlobeNewswire Inc.	argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies	NASDAQ:ARGX	argenx SE
2024/11/12	20:35	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ARGX	argenx SE
2024/11/11	21:30	GlobeNewswire Inc.	argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China	NASDAQ:ARGX	argenx SE
2024/11/11	21:30	Business Wire	Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China	NASDAQ:ARGX	argenx SE
2024/11/05	15:00	GlobeNewswire Inc.	argenx to Participate at Upcoming Investor Conferences	NASDAQ:ARGX	argenx SE
2024/10/31	21:15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ARGX	argenx SE
2024/10/31	15:00	GlobeNewswire Inc.	argenx Reports Third Quarter 2024 Financial Results and Provides Business Update	NASDAQ:ARGX	argenx SE
2024/10/24	14:00	GlobeNewswire Inc.	argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024	NASDAQ:ARGX	argenx SE
2024/10/15	21:14	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ARGX	argenx SE
2024/10/15	14:00	GlobeNewswire Inc.	argenx Highlights Data Showing Patient Impact Across Multiple Immunology Programs at 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and Myasthenia Gravis Foundation of America Scientific Sessions	NASDAQ:ARGX	argenx SE
2024/09/19	19:06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ARGX	argenx SE
2024/09/19	14:00	GlobeNewswire Inc.	argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy	NASDAQ:ARGX	argenx SE
2024/08/28	14:00	GlobeNewswire Inc.	argenx to Present at Upcoming Investor Conferences	NASDAQ:ARGX	argenx SE
2024/07/25	19:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ARGX	argenx SE
2024/07/25	14:00	GlobeNewswire Inc.	argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update	NASDAQ:ARGX	argenx SE
2024/07/18	14:00	GlobeNewswire Inc.	argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024	NASDAQ:ARGX	argenx SE
2024/07/17	06:22	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ARGX	argenx SE

검색 관련기사 보기:NASDAQ:ARGX

1 2 3 4 5 6 7 8 9 10 다음 >>

JP Morgan Chase

American Express

US Dollar vs Yen

Health Care Select Sector

Financial Select Sector

Deutsche Telekom (QX)

US Dollar vs Euro

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관